Skip to main content
Year archive

MEMPHASYS LIMITED. — 2025 filings

All 90 regulatory filings released by MEMPHASYS LIMITED. (MEM) in 2025, sourced directly from the official regulator.

90 Filings
2025 Period
2025 filings (90)
Filing Released Lang
Application for quotation of securities - MEM 7 pages 21.5KB
Share Issue/Capital Change
2025-12-30 English
Notification regarding unquoted securities - MEM 11 pages 31.9KB
Share Issue/Capital Change
2025-12-30 English
Section 708A Cleansing Statement 2 pages 281.8KB
Capital/Financing Update
2025-12-30 English
Placement of Shortfall Securities from the Entitlement Offer 2 pages 260.3KB
Capital/Financing Update
2025-12-29 English
Notification regarding unquoted securities - MEM 6 pages 18.7KB
Share Issue/Capital Change
2025-12-29 English
Application for quotation of securities - MEM 6 pages 19.0KB
Share Issue/Capital Change
2025-12-29 English
Notification regarding unquoted securities - MEM 5 pages 17.0KB
Share Issue/Capital Change
2025-12-29 English
Memphasys Extends Convertible Note Repayment Terms 2 pages 300.4KB
Capital/Financing Update
2025-12-29 English
Section 708A Cleansing Statement 2 pages 287.6KB
Capital/Financing Update
2025-12-29 English
Memphasys Secures CE Mark Approval for Felix System 4 pages 382.5KB
Capital/Financing Update
2025-12-28 English
Change of Director's Interest Notices x2 6 pages 682.9KB
Director's Dealing
2025-12-28 English
Trading Halt 2 pages 400.2KB
Regulatory Filings
2025-12-23 English
Memphasys Secures Long-Term European Supply Agreement 3 pages 334.5KB
Capital/Financing Update
2025-12-21 English
Application for quotation of securities - MEM 6 pages 18.7KB
Share Issue/Capital Change
2025-12-18 English
Application for quotation of securities - MEM 6 pages 18.7KB
Share Issue/Capital Change
2025-12-18 English
Notification regarding unquoted securities - MEM 5 pages 17.2KB
Share Issue/Capital Change
2025-12-18 English
Notification regarding unquoted securities - MEM 8 pages 27.4KB
Share Issue/Capital Change
2025-12-18 English
Key MENA Partner Secures Early Felix Cartridge Order 3 pages 286.2KB
Capital/Financing Update
2025-12-17 English
Memphasys Implements Leadership Restructure 2 pages 300.8KB
Board/Management Information
2025-12-09 English
Felix Middle East Direct Sales Strategy 3 pages 368.0KB
Capital/Financing Update
2025-12-07 English
AGM Chair Address 3 pages 167.4KB
AGM Information
2025-11-19 English
AGM Presentation 19 pages 1.4MB
Investor Presentation
2025-11-19 English
Results of Annual General Meeting 2 pages 413.8KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-19 English
Application for quotation of securities - MEM 6 pages 18.7KB
Share Issue/Capital Change
2025-11-10 English
Section 708A Cleansing Statement 2 pages 219.5KB
Capital/Financing Update
2025-11-10 English
Completion of Entitlement Offer 3 pages 144.5KB
Capital/Financing Update
2025-11-09 English
Application for quotation of securities - MEM 6 pages 18.5KB
Share Issue/Capital Change
2025-11-09 English
Notification regarding unquoted securities - MEM 5 pages 17.3KB
Share Issue/Capital Change
2025-11-09 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 307.4KB
Interim / Quarterly Report Q1 2026
2025-10-30 English
MEM Secures Indian Supply Deal Under Go-Direct Strategy 4 pages 193.0KB
Capital/Financing Update
2025-10-27 English
Director's Interest Notices 10 pages 1.1MB
Director's Dealing
2025-10-26 English
Memphasys Expands Felix Commercial Footprint in Japan 3 pages 165.0KB
Capital/Financing Update
2025-10-23 English
Notice of Annual General Meeting/Proxy Form 49 pages 1.2MB
AGM Information
2025-10-20 English
Proposed issue of securities - MEM 5 pages 18.0KB
Capital/Financing Update
2025-10-20 English
Board Changes 2 pages 117.7KB
Board/Management Information
2025-10-19 English
Response to ASX Aware Letter 8 pages 291.3KB
Regulatory Filings
2025-10-19 English
Rights Issue Prospectus despatched 2 pages 148.4KB
Capital/Financing Update
2025-10-09 English
Company Secretary Appointment/Resignation 1 page 13
Board/Management Information
2025-10-07 English
Update - Proposed issue of securities - MEM 8 pages 28.7KB
Capital/Financing Update
2025-10-02 English
Non-Renounceable Issue 39 pages 622.1KB
Capital/Financing Update
2025-10-01 English
Proposed issue of securities - MEM 7 pages 26.0KB
Capital/Financing Update
2025-10-01 English
Proposed issue of securities - MEM 8 pages 28.9KB
Capital/Financing Update
2025-10-01 English
Application for quotation of securities - MEM 6 pages 18.5KB
Share Issue/Capital Change
2025-09-30 English
Cleansing Statement 1 page 180.9KB
Capital/Financing Update
2025-09-30 English
Annual Report to shareholders 68 pages 2.0MB
Annual Report FY 2025
2025-09-29 English
LR4.3D - adjustment to financial statements 2 pages 189.8KB
Regulatory Filings
2025-09-29 English
Appendix 4G and Corporate Governance Statement 24 pages 672.6KB
Governance Information
2025-09-29 English
Investor Webinar Invititation for 25 Sept 2025 2 pages 193.0KB
Investor Presentation
2025-09-24 English
Investor Presentation - commercialisation of FELIX 20 pages 1.8MB
Investor Presentation
2025-09-24 English
Placement Accelerates Felix Commercialisation and Manufactur 4 pages 265.5KB
Capital/Financing Update
2025-09-21 English
Proposed issue of securities - MEM 6 pages 21.6KB
Capital/Financing Update
2025-09-21 English
Memphasys Secures Significant ITL Contract Upgrade 3 pages 242.4KB
Capital/Financing Update
2025-09-17 English
Trading Halt 2 pages 292.9KB
Capital/Financing Update
2025-09-17 English
Board update 1 page 191.1KB
Board/Management Information
2025-09-10 English
Final Director's Interest Notice PW 2 pages 171.1KB
Director's Dealing
2025-09-10 English
FELIX landmark commercial agreement signed for MENA region 3 pages 226.4KB
Capital/Financing Update
2025-09-07 English
Preliminary Final Report 17 pages 704.1KB
Annual Report FY 2025
2025-08-28 English
Presentation to Shareholders at General Meeting 22 pages 765.0KB
Investor Presentation
2025-08-07 English
Results of Meeting 1 page 53.3KB
Declaration of Voting Results & Voting Rights Announcements
2025-08-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 395.2KB
Interim / Quarterly Report Q4 2025
2025-07-29 English
Shareholder Meeting 8 August 2025 - Change of meeting venue 1
Regulatory Filings
2025-07-24 English
Director Resignation 1 page 191.5KB
Board/Management Information
2025-07-24 English
Final Director's Interest Notice MA 2 pages 188.2KB
Director's Dealing
2025-07-24 English
Notice of General Meeting/Proxy Form 14 pages 573.4KB
Proxy Solicitation & Information Statement
2025-07-07 English
CE Mark Lodged for Felix to Expand Global Access 3 pages 331.7KB
Capital/Financing Update
2025-06-29 English
Director Appointment - Marjan Mikel 2 pages 335.5KB
Board/Management Information
2025-06-18 English
Details of Auditor Appointment/Resignation 1 page 2
Audit Report / Information FY 2025
2025-05-25 English
MEM Successfully trials RoXsta Mega Cell High-Throughput 2 pages 291.3KB
Regulatory Filings
2025-05-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.7MB
Interim / Quarterly Report Q3 2025
2025-04-29 English
Notification regarding unquoted securities - MEM 6 pages 19.7KB
Share Issue/Capital Change
2025-04-16 English
Application for quotation of securities - MEM 6 pages 18.5KB
Share Issue/Capital Change
2025-04-16 English
s708A Cleansing Statement 1 page 181.2KB
Capital/Financing Update
2025-04-16 English
$1.275M Placement to Accelerate Commercial Rollout 3 pages 288.3KB
Capital/Financing Update
2025-04-13 English
Update - Proposed issue of securities - MEM 6 pages 21.1KB
Capital/Financing Update
2025-04-13 English
Proposed issue of securities - MEM 6 pages 21.0KB
Capital/Financing Update
2025-04-09 English
Pause in Trading 1 page 117.8KB
Regulatory Filings
2025-04-09 English
Trading Halt 2 pages 210.4KB
Capital/Financing Update
2025-04-09 English
RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle 3 pages 353.1KB
Regulatory Filings
2025-04-02 English
Felix Trial Confirms Best-in-Class Performance 3 pages 267.1KB
Capital/Financing Update
2025-03-23 English
Trading Halt 2 pages 283.6KB
Regulatory Filings
2025-03-19 English
MEM secures R&D Tax Rebate loan 1 page 236.8KB
Capital/Financing Update
2025-03-12 English
Extension of Convertible Notes 1 page 185.5KB
Capital/Financing Update
2025-02-27 English
Half Yearly Report and Accounts 23 pages 1.9MB
Interim / Quarterly Report H1 2025
2025-02-27 English
Investor Presentation Feb 25 43 pages 4.8MB
Investor Presentation
2025-02-24 English
Felix Data lock complete and regulatory submission commenced 2 pages 254.4KB
Capital/Financing Update
2025-02-23 English
Leading Brazilian Andrology Clinic to test Felix System 3 pages 245.3KB
Capital/Financing Update
2025-02-16 English
Felix Clinical Trial complete, Data Lock expected in 2 weeks 2 pages 231.6KB
Regulatory Filings
2025-02-10 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 604.0KB
Interim / Quarterly Report Q2 2025
2025-01-22 English
Publication Highlights Diagnostic Potential of RoXsta TM 3 pages 252.4KB
Regulatory Filings
2025-01-15 English
Heranova Felix System Utilisation Testing commences in China 3 pages 250.0KB
Regulatory Filings
2025-01-05 English